1 hr ago
EYLEAA (aflibercept) Injection Receives FDA Approval for the...
The recommended dosage of EYLEA in patients with DME is 2 milligrams every two months after five initial monthly injections.
8 hrs ago
The unintended consequences of well-meaning FDA regulations
We rely on the FDA to protect public health "by assuring the safety, efficacy, and security" of medical drugs and devices.
10 hrs ago
Ophthotech Corporation to Announce Second Quarter 2014 Financial...
Ophthotech Corporation today announced that it will release its financial results for the second quarter ended June 30, 2014, on Wednesday, August 6, 2014.
Mon Jul 28, 2014
Avalanche Biotechnologies IPO This Week: Watch Out Below
AAVL, a clinical-stage biotechnology firm, engaged in the discovery and development of gene therapies for the treatment of ophthalmic diseases, plans to raise $75.6 million in its upcoming IPO.
Sat Jul 26, 2014
The Miami Herald
Ask Nancy: What to do when your elderly neighbor needs help
My next-door neighbors for the past 30 years are two elderly women who are now in their eighties.
Fri Jul 25, 2014
Lincoln Daily News
Eye-opening facts about aging eyes and vision problems
Most Americans know that vision problems begin to increase as they age. What they may not realize is that reduced vision is also linked to a higher frequency of falls, injuries and depression.
Promising results from gene therapy research to treat macular degeneration
AMD is the leading cause of blindness in the developed world and statistics suggest that it affects one in seven Australians over the age of 50. The dry form of the disease cannot be treated but wet AMD can be with regular drug injections to stop the growth of a problem protein and halt vision deterioration.
In the line of sight: Growing cases, new treatments on the horizon...
About macular degeneration Age-related macular degeneration affects close to 2 million Americans.
Age-Related Macular Degeneration--Optometry and Vision Science Presents Research Update
Newswise - July 25, 2014 - Recent years have seen major strides in basic science and clinical research on age-related macular degeneration -the leading cause of vision loss in older adults.
Maley's 90th birthday charity plunge goes swimmingly
MALEY Abbott had a splashing 90th birthday as she celebrated by giving something back to those who have helped her.
Alnylam And Benitec
Alnylam is a $5.1B company and Benitec Biopharma is a $120M company. Both are biotech companies working in the field of RNAi .
Yellow Crookneck Squash Salad
It is a staple food for Native American tribes, and is among the oldest and most cultivated crops.
Thu Jul 24, 2014
Behavior therapy may help prevent depression over vision loss
Combining occupational therapy to help older people adapt to central vision loss with behavior therapy to keep them from becoming too isolated may prevent depression, according to a new study.
Patent Application Titled 'Chromatography Filter Paper-Based Elisa' Published Online
Reporters obtained the following quote from the background information supplied by the inventors: "The present invention relates to a chromatography filter paper-based ELISA and more particularly to a chromatography filter paper-based ELISA for lesion analysis of ocular angiogenesis.
'The eye and the brain are connected, so it's no surprise lutein...
Lutein and zeaxanthin are well-established in the realm of eye health, but ever emerging science shows the importance of the carotenoids in brain health.
Wed Jul 23, 2014
July Biotech Blitz And The Upcoming Eye, Ear And Nose IPOs
If IPO sectors typically arrive in waves, then 2014 has been a tsunami of biotechs, particularly during February and March .
Tue Jul 22, 2014
Oraya Therapy now being offered at NHS hospital in the UK and at four ...
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany.
Dorset County Hospital eye clinic shortlisted for prestigious award
DORSET County Hospital's eye clinic has been shortlisted for a national award after being labelled as "exceptional" by its patients.
Early stage AMD can occur much earlier than previously thought
It is widely accepted that age-related macular degeneration is the most common cause of visual impairment and blindness in industrialized countries.
Mon Jul 21, 2014
StemCells Inc. Announces Closing Of $20 Million Offering
StemCells, Inc. , today announced that it has closed its previously announced offering of common stock and short term warrants.